BIOINVENT AB
(OTC) BOVNF
BIOINVENT AB Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$226.46M
Net Income (TTM)
$332.02M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BOVNF News
BOVNF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BIOINVENT AB
Industry
Biotechnology
Sector
Health CareEmployees
109
CEO
Martin Welschof, PhD
Website
www.bioinvent.comHeadquarters
Lund, 223 70, SE
BOVNF Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-2%
Net Income Margin
-1%
Return on Equity
-47%
Return on Capital
-63%
Return on Assets
-50%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$226.50M
Operating Income
$350.51M
EBITDA
$330.69M
Operating Cash Flow
$247.13M
Capital Expenditure
$7.24M
Free Cash Flow
$254.38M
Cash & ST Invst.
$591.26M
Total Debt
$9.66M
BIOINVENT AB Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.01M
-85.9%
Gross Profit
$3.02M
-85.9%
Gross Margin
1.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
114
N/A
Net Income
$126.19M
-8.0%
EBITDA
$124.19M
-2.6%
Quarterly Fundamentals
Net Cash
$581.60M
-31.6%
Accounts Receivable
$32.57M
+294.1%
Inventory
$12.26M
+11.8%
Long Term Debt
$2.31M
-71.9%
Short Term Debt
$7.35M
-20.1%
Return on Assets
-49.59%
N/A
Return on Invested Capital
-62.97%
N/A
Free Cash Flow
$91.60M
+7.6%
Operating Cash Flow
$90.32M
+8.1%